Patients sue Gilead, saying drug company intentionally delayed safer HIV medicine - Los Angeles Times
Gilead to launch generic versions of hepatitis C drugs | Modern Healthcare
Gilead says counterfeiters sold $250M worth of fake HIV drugs, sues distributors | Fierce Pharma
Trump administration sues Gilead over HIV drugs
India and Pakistan ramp up remdesivir production under Gilead deal | Financial Times
Trump administration sues Gilead over HIV drugs
Gilead to Slice List Prices of Liver Drugs - WSJ
Study: To be cost-effective, Gilead's new HIV pill needs near-50% price cut
Gilead Sciences, Inc.
Gilead drug remdesivir shows promise in two coronavirus trials
United States v. Gilead: The Fight for PrEP | Bill of Health
FDA approves Gilead's multi-drug resistant HIV-1 treatment
Gilead Advancing Access®: What to Know | Prism Health North Texas
Change to Gilead assistance program threatens PrEP access, HIV advocates say | PBS NewsHour
Gilead Revenue Soars on Hepatitis C Drug - The New York Times
Examining the Truvada #BreakThePatent Debate: Gilead Responds
Antitrust HIV drugs case should be arbitrated, argue Gilead, BMS
Generic HIV prevention drug coming in 2020, Gilead says
Sovaldi: Who's to Blame for the $1,000 a Day Cure? - Knowledge at Wharton
Gilead prices remdesivir at $2,340 per patient for developed countries
AHF • AHF Calls on Gilead to Set Up $10 Billion Fund for Victims Harmed by its TDF-based Drugs
Gilead's Biktarvy wins megablockbuster HIV nod, and rival GlaxoSmithKline strikes back | Fierce Pharma
Gilead says generic Truvada will be available in 2020
Gilead to donate HIV prevention drug Truvada to 200K uninsured patients
Gilead bags EU approval for next-generation HIV drug - PMLiVE
Single patient study adds to debate over Gilead's remdesivir for COVID-19 | Reuters
